Elevance Health Inc (ELV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Elevance Health Inc (ELV) has a cash flow conversion efficiency ratio of 0.098x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($4.33 Billion) by net assets ($44.04 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ELV equity to assets ratio to measure how much of total assets are equity-financed.
Elevance Health Inc - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Elevance Health Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Elevance Health Inc to evaluate the quality of earnings relative to operating cash generation.
Elevance Health Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Elevance Health Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CSX Corporation
NASDAQ:CSX
|
0.094x |
|
MercadoLibre Inc.
NASDAQ:MELI
|
0.285x |
|
Medtronic PLC
XETRA:2M6
|
0.052x |
|
Datadog Inc
NASDAQ:DDOG
|
0.084x |
|
Glencore plc
MX:GLENN
|
0.089x |
|
Howmet Aerospace Inc
NYSE:HWM
|
0.103x |
|
3M Company
NYSE:MMM
|
0.173x |
|
American Tower Corp
NYSE:AMT
|
0.135x |
Annual Cash Flow Conversion Efficiency for Elevance Health Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of Elevance Health Inc from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Elevance Health Inc market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $44.03 Billion | $4.29 Billion | 0.097x | -30.50% |
| 2024-12-31 | $41.43 Billion | $5.81 Billion | 0.140x | -31.46% |
| 2023-12-31 | $39.41 Billion | $8.06 Billion | 0.205x | -11.51% |
| 2022-12-31 | $36.33 Billion | $8.40 Billion | 0.231x | -0.14% |
| 2021-12-31 | $36.13 Billion | $8.36 Billion | 0.232x | -28.09% |
| 2020-12-31 | $33.20 Billion | $10.69 Billion | 0.322x | +68.53% |
| 2019-12-31 | $31.73 Billion | $6.06 Billion | 0.191x | +42.47% |
| 2018-12-31 | $28.54 Billion | $3.83 Billion | 0.134x | -15.08% |
| 2017-12-31 | $26.50 Billion | $4.18 Billion | 0.158x | +23.68% |
| 2016-12-31 | $25.10 Billion | $3.20 Billion | 0.128x | -28.52% |
| 2015-12-31 | $23.04 Billion | $4.12 Billion | 0.179x | +28.56% |
| 2014-12-31 | $24.25 Billion | $3.37 Billion | 0.139x | +12.72% |
| 2013-12-31 | $24.77 Billion | $3.05 Billion | 0.123x | +6.89% |
| 2012-12-31 | $23.80 Billion | $2.74 Billion | 0.115x | -20.42% |
| 2011-12-31 | $23.29 Billion | $3.37 Billion | 0.145x | +143.55% |
| 2010-12-31 | $23.81 Billion | $1.42 Billion | 0.059x | -51.32% |
| 2009-12-31 | $24.86 Billion | $3.04 Billion | 0.122x | +3.32% |
| 2008-12-31 | $21.43 Billion | $2.54 Billion | 0.118x | -37.40% |
| 2007-12-31 | $22.99 Billion | $4.34 Billion | 0.189x | +14.84% |
| 2006-12-31 | $24.58 Billion | $4.04 Billion | 0.165x | +26.29% |
| 2005-12-31 | $24.99 Billion | $3.26 Billion | 0.130x | +94.57% |
| 2004-12-31 | $19.46 Billion | $1.30 Billion | 0.067x | -64.86% |
| 2003-12-31 | $6.00 Billion | $1.14 Billion | 0.191x | +3.11% |
| 2002-12-31 | $5.36 Billion | $991.10 Million | 0.185x | -41.84% |
| 2001-12-31 | $2.06 Billion | $654.60 Million | 0.318x | -10.88% |
| 2000-12-31 | $1.92 Billion | $684.50 Million | 0.357x | -- |
About Elevance Health Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad… Read more